Korea's leading 500 insurance drugs pricing under-evaluated by 57 percent

Korea's top 500-drug prices covered by the national health insurance is in the level of 57.1 percent compared with those of seven advanced countries, according to a report released by the Korea Pharmaceutical Manufacturers Association (KPMA) on December 14.

By country, the average insurance price of Korea's top 500-drug prices accounts for 33 percent of the United States, 57 percent of Switz...